Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
Bokskapet / Pixabay

Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension

According to a story from Benzinga, the medical device company V-Wave Ltd. has recently announced that a product in development by the company has earned Breakthrough Device designation from the…

Continue Reading Company Earns Breakthrough Device Designation for Pulmonary Arterial Hypertension
Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
argzombies / Pixabay

Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease

According to a story from clinicaltrials.gov, the Children's Hospital of Philadelphia is sponsoring a study that has the potential to make mitochondrial disease research and drug development much easier. The…

Continue Reading Study to Test Possible Biomarker for Myopathy Associated With Mitochondrial Disease
ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug
rawpixel / Pixabay

ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug

According to a press release from CTD Holdings, the American Food and Drug Administration (FDA) recently approved an Expanded Access application from a physician to treat a pediatric Niemann-Pick disease…

Continue Reading ICYMI: FDA Approves Expanded Access Application of Experimental Niemann-Pick Type C Drug